Stoneridge Investment Partners LLC Makes New $993,000 Investment in Danaher Corporation $DHR

Stoneridge Investment Partners LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 5,095 shares of the conglomerate’s stock, valued at approximately $993,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Northwestern Mutual Wealth Management Co. boosted its holdings in Danaher by 303.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after purchasing an additional 186,584 shares in the last quarter. Legal & General Group Plc raised its holdings in shares of Danaher by 1.0% in the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after buying an additional 43,169 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Danaher by 51.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 271,734 shares of the conglomerate’s stock worth $62,205,000 after buying an additional 92,323 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Danaher by 41.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 168,163 shares of the conglomerate’s stock worth $38,496,000 after buying an additional 49,559 shares during the period. Finally, Advisors Capital Management LLC lifted its position in shares of Danaher by 14.0% during the 4th quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock worth $12,555,000 after buying an additional 6,720 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Down 0.7%

Shares of DHR opened at $202.51 on Friday. The company has a market capitalization of $142.37 billion, a P/E ratio of 35.97, a PEG ratio of 2.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The business’s 50 day simple moving average is $193.14 and its 200-day simple moving average is $193.21.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the company earned $0.77 EPS. Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. As a group, sell-side analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently commented on DHR. TD Cowen decreased their price target on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Stifel Nicolaus dropped their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Argus cut their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. Morgan Stanley reduced their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $245.00 target price on shares of Danaher in a report on Tuesday, April 21st. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.